chrisvoncsefalvay/vaers-outcomes huggingface dataset:
t + 3 hours: onset of arm pain and limited arm mobility  t + ~5 hours: onset of join pain, body aches, fatigue, dizziness, reduced appetite.  t +~7 hours: onset of muscle pain throughout body, chills/shivering/teeth chattering, muscle weakness and lack of coordination (dropping items, unable to hold items in hands), no appetite  t + ~9 hours: extreme chills, teeth chattering, inability to keep warm even with lots of layers and blankets, confusion, dizziness, migraine, fever (temp unknown); took 400mg ibuprofen to reduce headache and body pain, exposure to light causes eye/head pain  t+~12 hours: extreme weakness and muscle aches, moving at all causes waves of chills and pain throughout body, severe migraine with aura, moving or standing is very difficult to impossible, lack of balance and coordination, fever (temp unknown), profuse sweating enough to soak through clothes. Weakness such that a glass of water 1ft away cannot be lifted. Had to get up to go to bathroom, and had to prop myself up on furniture and walls to make it the  15ft to the bathroom from bed.  t + ~24 hours: some muscle weakness, fever cleared, generally feeling well with some aches and tiredness.  Felt sicker than I've ever been in my life -- like influenza but more extreme symptoms with shorter duration.
This spontaneous report as received from a nurse refers to a unknown number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with RECOMBIVAX HB. No co-suspect and concomitant therapies were reported. The nurse reported that an unknown number of patients received improperly stored RECOMBIVAX HB, on unkonwn dates. No adverse symptoms reported. The temperature excursion for RECOMBIVAX HB, was found to be unsupported excursion with in-house stability data. This is one of several reports from the same source. Additional information has been requested.
74 y.o. female with a history of hypertension and hyperlipidemia who was admitted to this hospital on February 25, 2020 4 hours after the development of left-sided weakness.  She was found to have an acute ischemic stroke.  She has had slow progression with therapy but is now able to ambulate with a walker.  She is in need of further rehab, hence the transition to swing bed.  She denies any new complaints today, including headache, chest pain, shortness of breath, palpitations or feelings of tachyarrhythmias.  The sensory deficits on the left side have improved in particular in her left upper extremity.  She is noting some improvement as well and strength.  No new focal neurological deficits
pt recvd vax; exp severe n, fever, body aches & v;to er due to cont v;
Right arm tender and red, aching after receiving pneumonia shot. She called her MD, took Benadryl and Motrin, put ice pack on it - 11/1/02 called PT - redness resolved feeling fine. Case closed.
Patient states he received the Pfizer two dose series in the spring of 2021 - unable to provide place nor exact dates of vaccination.  Patient presented to ED suffering from SOA, abdominal pain, cough, hiccups, decreased appetite.    This report includes all known requested statistics, questions intentionally left blank.
Sudden fever of 102.6 climbing up to 104.5 the first night. Continued to battle fevers between 102 and 106.1 for 10 days, then fever dropped to the range of 99.5-102 for 3 days before finally disappearing. Also had intense, painful chills, nausea, splitting headache and altered sense of smell. Had 2 visits to the ER and multiple tests were done, including blood tests, chest x-ray, CT scan  and multiple covid-19 tests.  None of these tests were abnormal, leaving my doctors to conclude that my illness was probably the product of an extreme immune reaction to the booster shot. I am recovered now but extremely weak and fatigued.
PT RECEIVED VACCINE AND FAINTED WHEN STANDING IN LINE FOR CHECKOUT. PT STATED HE DID NOT EAT BREAKFAST. EMS ASSIST WAS CALLED AND PT ESCORTED TO ER
On the top corner of the lip it feels like blisters inside,It's on both sides of my mouth, right on the top inside edge; Not sure what they are, if blisters or Canker Sores; Can't open mouth; Fever of 101 to 103/had temperature of 99; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (On the top corner of the lip it feels like blisters inside,It's on both sides of my mouth, right on the top inside edge), APHTHOUS ULCER (Not sure what they are, if blisters or Canker Sores), TRISMUS (Can't open mouth) and PYREXIA (Fever of 101 to 103/had temperature of 99) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 030L20A and 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and BP.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, the patient experienced PYREXIA (Fever of 101 to 103/had temperature of 99). On 22-Nov-2021, the patient experienced ORAL MUCOSAL BLISTERING (On the top corner of the lip it feels like blisters inside,It's on both sides of my mouth, right on the top inside edge), APHTHOUS ULCER (Not sure what they are, if blisters or Canker Sores) and TRISMUS (Can't open mouth). On 21-Nov-2021, PYREXIA (Fever of 101 to 103/had temperature of 99) had resolved. At the time of the report, ORAL MUCOSAL BLISTERING (On the top corner of the lip it feels like blisters inside,It's on both sides of my mouth, right on the top inside edge), APHTHOUS ULCER (Not sure what they are, if blisters or Canker Sores) and TRISMUS (Can't open mouth) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Nov-2021, Body temperature: 101 to 103 (High) Fever of 101 to 103. On 21-Nov-2021, Body temperature: 99 (High) Had temperature of 99.         Concomitant medication included blood pressure medication and cholesterol medication.  No treatment information was provided. Patient was not sure what they were, if blisters or canker sores.
Per a Regulatory Authority and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Patient dizzy after vaccine laid back and appear to have fainted. Recovered in less than 30 seconds awake alert and oriented.
Pt. is pregnant (not sure how many months) she said she felt weak and her throat swelled up, felt pressure on chest for 30 minutes. She went to ER. ER doctor couldn't find anything wrong with her. She told pharmacist she has a latex allergy. Rph found out Boostrix may be cause of reaction since rubber cap tip is made of latex. Pt did mark "no allergy to latex" on consent form. but came back to pharmacy 2 weeks later to tell us she does have allergy to latex.
Set up for a covid-19 vaccine, did not realize that expiration had passed. gave patient vaccine, patient has no reactions and provider contacted patient.
Information has been received from a healthcare worker concerning a 69 year old female patient who had experienced an unspecified allergic reaction after received a dose of PNEUMOVAX (lot #663012/1163X). The patient sought medical attention through a office call. Follow up information indicated that the patient also experienced a spot at the injection site with a rash. Follow up information received on 04-APR-2009 from a health professional stated that it was a white retired female teacher who complained of redness, heat and swelling at the injection site on 17-NOV-2008. The patient had recovered. This is one of three reports from the same source. No further information is available.
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 04-DEC-2014, the patient was vaccinated with a dose of MMR II (route, dose, frequency and lot # not reporter) which had undergone an temperature excursion. This is one of several reports from the same source. Additional information has been requested.
Fever, crying non stop x 1-2 hr. 2/18/09 - temp 101 this mother has cystic fibrosis - not breastfeeding.
I experience swelling under my left arm; This is a spontaneous report from a contactable consumer (Patient).  A 38-year-old patient of an unspecified gender received BNT162B2 (Pfizer/BioNTech COVID-19 Formulation: Solution for injection, Batch/Lot Number: EL8982 Expiration Date: Unknown) via an unspecified route of administration, administered in Upper Left Arm on 14Jan2021 at 16:30 (at the age of 38-year-old) as dose 1 single for covid-19 immunization.  Patients Medical history and concomitant medications were not reported. After receiving first dose patient experienced swelling under left arm in Jan2021.Patient received 2nd dose (31Jan2021), 4-6 hours later patient  had headache, body aches, low grade fever, severe swelling under left arm, pain in arm to include fingers and fatigue. These symptoms persisted until 04Feb2021. An outcome of an event was unknown.  Follow-up attempts are completed. No further information is expected.
Dermatitis reaction; Lips were big; Face was numb; Face got swollen like she had a food allergy; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS (Dermatitis reaction), LIP SWELLING (Lips were big), HYPOAESTHESIA (Face was numb) and SWELLING FACE (Face got swollen like she had a food allergy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced DERMATITIS (Dermatitis reaction) (seriousness criterion medically significant), LIP SWELLING (Lips were big) (seriousness criterion medically significant), HYPOAESTHESIA (Face was numb) (seriousness criterion medically significant) and SWELLING FACE (Face got swollen like she had a food allergy) (seriousness criterion medically significant). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DERMATITIS (Dermatitis reaction), LIP SWELLING (Lips were big) and HYPOAESTHESIA (Face was numb) outcome was unknown and SWELLING FACE (Face got swollen like she had a food allergy) was resolving.            Concomitant drugs were not reported.  This case concerns a 40 year-old female patient with no reported medical history who experienced the unexpected serious events of dermatitis, lip swelling, hypoaesthesia and swelling of face. The events occurred approximately 2 days after the third dose of mRNA-1273. The rechallenge was not applicable as no additional dosing will be administered. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 40 year-old female patient with no reported medical history who experienced the unexpected serious events of dermatitis, lip swelling, hypoaesthesia and swelling of face. The events occurred approximately 2 days after the third dose of mRNA-1273. The rechallenge was not applicable as no additional dosing will be administered. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Information has been received from a nurse referring to unspecified number of patients of unknown age and gender. The patients' pertinent medication, drug reactions/allergies and concomitant medication were not reported. From 01-AUG-2016 to 09-AUG-2016, the patients were vaccinated with improperly stored doses of M-M-R II (lot # L032182 with expiration date 25-AUG-2017; dose, dose number and route were not reported). No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
Patient received her vaccine and during the 15 minute observation period, her husband called us over. She was extremely sweaty, had clammy hands, eyes were fading in and out, and appeared as if she was about to pass out twice.  No reports of trouble breathing. Called 911, stayed with patient until the paramedics came who then escorted her.
12Mar91 530pm began vomiting , c/o severe headache-T 103-oral. Vomited all day on 13Mar91. Able to tolerate liquids on 14Mar91. AM of 13Mar91 became listless T.C. to MD-MD says it is probably flu.
Patient was bleeding and had a ~2cm diameter raised bump at injection site. Patient felt flushed and hot. Patient was requested to stay seated under observation for about 15-30 minutes. 50mg of diphenhydramine liquid was administered orally. Patient refused any other treatment reported to be fine an hour later.
pain at injection sites beginning at 7pm.  Full body aches, pain, fever, night sweat, chills started at 10pm.  Redness and swelling at injection site, headache, blurred vision, mild delirium. These symptoms continued for 48 hrs.  Blurred vision, sinus pain, swelling and extreme pain redness at injection site on right arm lasted for 5 days.  Day 6 vision is clear, Right arm remains sore. Redness is faded, but I have use of arm on day 7.
Fever 102.5 with severe headache, and fast pounding heart rate (did not think to take pulse at the time) fever lasted two days with headache dizziness and fast heartrate.
Within 30 minutes of receiving the first dose of the COVID vaccine, I ban to feel tingling on the left side of my face.  Within another 30 minutes, I had multiple blisters in the same spot.  Within another 2 hours, the lymph nodes on the left side of my neck were swollen.
Some bruising after my first dose away from the infection site near some spider veins in my leg; This spontaneous case was reported by a patient and describes the occurrence of CONTUSION (Some bruising after my first dose away from the infection site near some spider veins in my leg) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (Some bruising after my first dose away from the infection site near some spider veins in my leg). At the time of the report, CONTUSION (Some bruising after my first dose away from the infection site near some spider veins in my leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not received.  Treatment medications were not reported.
Crying on arrival & cried whole visit nurse noted slight pinkness @ inject site rt arm, blotchy pinkish red rash upper chest, upper back & cheeks. Rash faded in 20mins in MD office.
Patient received first covid vaccine at 4:58 and walked to the observation room. He was seated in chair and had a syncope episode. BP was 100/50, pulse 50. Patient was diaphoretic and nauseated. Would regain consciousness but then would lose consciousness. He would answer questions appropriately but cold not stay awake or remain conscious. A rapid response was called and ER arrived
was vaccinated and still got Shingles/Suspected vaccination failure; Shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patient was the reporter's niece. The age at vaccination was not reported. The patient received shingles vaccine and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
2 patients received expired dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 patients received expired dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 patients received expired dose). On 21-Sep-2021, EXPIRED PRODUCT ADMINISTERED (2 patients received expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter. No Treatment information was reported. Vial was initially stored in the Refrigerator on 16-Aug-2021.
I had chills, body aches, headache and very fatigued about six hours after receiving the vaccine for about 24 hours. I had a drippy nose, a slight cough, I felt really run down prior to testing positive for COVID-19. I tested positive for COVID-19 on 09/15/2022. I contacted your doctor and got a prescription for PAXLOVID. I didn't start taking the prescription until 09/16/2022 due to concerns about other medications I am taking. I tolerated the medication well enough except for the taste. I did lose my sense of taste and smell. I did rebound which lasted about three days. The headaches and eye pain were the toughest and long-lasting symptom.
I obtained my first injection of the SHINGRIX vaccine on 4/13/18. Second injection to be 2-6 months later. Not sure if I should obtain second injection??? Experienced the following day 4/14/18 - redness, swelling and extreme soreness in my left arm where the injection was administered. Other side effects - muscle pain, feeling very fatigued, tired and weak. Upset stomach and diarrhea. These symptoms lasted 2-4 days following the date on first injection. Difficulty sleeping 4/13/18.
Right leg thigh to knee-generally swollen.  Not warm to touch, not red.  Able to it bear and touch area 1/s discomfort.  Father reported fever, but in office no fever.  Had Tylenol at 8:00.  Seen at 10:50am.  Well on 05/20/2003-says healthy child.
This spontaneous report as received from a pharmacist refers to a current 78 years old female patient with high triglycerides and without drug reactions. The patient was vaccinated with ZOSTAVAX (lot number unknown) on 01-MAR-2010. No other co-suspects were reported. Concomitant medications included TRICOR. In the past few days, in approximate August 2012, the patient developed shingles on her torso after vaccination with ZOSTAVAX. She had seen a dermatologist. Antiviral was given as treatment. The outcome was unknown. Additional information has been requested.
RESIDENT HAS BLISTERS/SHINGLES ON HER LEFT BACK AND UNDER ARM.
Received immunizations in morning.  In evening, developed 105 degree fever, swollen arm, lethargy, no appetite, headache.  Fever reduced somewhat with children's acetaminophen.  The next morning child stated she felt a little better but still complained of headache and swollen arm.
Noticed a tingling sensation started to itch slightly & then went to bed; Next morning pt was covered w/rash, spread over back; Took DPH;
This spontaneous report as received from a pharmacist refers to a 62 year old male patient. None pertinent medical history, drug reactions or allergies were reported. On an unknown date in October 2012 (also reported as "2 years ago"), the patient was vaccinated with ZOSTAVAX (dose, dose number, route, anatomical location, lot number and expiration date were unspecified). None concomitant therapies were reported. On an unknown date in 2012, after receiving ZOSTAVAX, the patient experienced a rash around the injection site. No treatment was given for the adverse event. The patient did not seek medical attention. None laboratory diagnostic studies were performed. The outcome of rash around the injection site was reported as recovered on an unknown date in 2012, "2 days after injection". The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
About 48 hours after injection: arm still very sore, red at injection site,  and developed swollen and sore lymph nodes in right arm (site of injection)
Initial and follow-up information has been received from a nurse, for GARDASIL, a Pregnancy Registry product, concerning a 23 year old female who on 07-JAN-2008 was vaccinated with the first dose of GARDASIL (lot# 659439/1267U, IM, 0.5ml). On 12-JUN-2008 the patient received the second dose of GARDASIL (lot# 660391/0063X, IM, 0.5ml). Concomitant therapy included LEXAPRO. After the second dose the patient was pregnant and her last menstrual period (LMP) date was at 15-AUG-2008. On 26-SEP-2008 the patient experienced pre-eclampsia and spotting/bleeding; intervention was observation. Lab diagnostics studies included ultrasounds-normal, fetal echocardiogram at 37 weeks-normal, urine protein test-normal. On 08-MAY-2009 the patient was admitted for delivery at hospital. The patient did experience "pregnancy induced hypertension" at delivery, but hospitalization was not prolonged due to this event. The baby boy (8lb 4oz) born with no complications. The patient was seen in the office on 21-JUL-2009, blood pressure (B/P) was normal (120/72) at that visit. The patient had not yet received the 3rd dose of GARDASIL. At the report time the patient's status was unknown. In follow-up, a nurse reported the 23 year old white female had no previous pregnancies. Her concurrent medical conditions were reported as "stable". Other medication used during her pregnancy included precare vitamin (the date of use was reported as "25-SEP-2009"). Her pregnancy was complicated by pregnancy-induced hypertension and she developed edema. Subsequently, on 09-MAY-2009, the patient delivered a normal male baby by C-section delivery weighing 8 pounds 4 ounces. The baby had no congenital anomalies or any other complications or abnormalities. No further information is available.